0001209191-23-049366.txt : 20230913
0001209191-23-049366.hdr.sgml : 20230913
20230913201619
ACCESSION NUMBER: 0001209191-23-049366
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230911
FILED AS OF DATE: 20230913
DATE AS OF CHANGE: 20230913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Lara
CENTRAL INDEX KEY: 0001769457
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40881
FILM NUMBER: 231253847
MAIL ADDRESS:
STREET 1: C/O REXAHN PHARMACEUTICALS, INC.
STREET 2: 15245 SHADY GROVE ROAD, SUITE 455
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pyxis Oncology, Inc.
CENTRAL INDEX KEY: 0001782223
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831160910
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: (617) 221-9059
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-09-11
0
0001782223
Pyxis Oncology, Inc.
PYXS
0001769457
Sullivan Lara
C/O PYXIS ONCOLOGY, INC.
321 HARRISON AVENUE
BOSTON
MA
02118
1
1
0
0
President and CEO
0
Common Stock
2023-09-11
4
S
0
20000
2.2707
D
2605182
D
Common Stock
2023-09-12
4
S
0
4917
2.2516
D
2600265
D
Common Stock
2023-09-13
4
S
0
3000
2.2719
D
2597265
D
Common Stock
2023-09-13
4
F
0
184742
2.13
D
2412523
D
Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 2 through 4 of this Form 4.
The transaction was executed in multiple trades in prices ranging from $2.13 to $2.36.
The transaction was executed in multiple trades in prices ranging from $2.21 to $2.30.
The transaction was executed in multiple trades in prices ranging from $2.25 to $2.34.
Represents shares withheld to cover taxes due upon the vesting of certain restricted stock units.
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
2023-09-13